Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MCHR1 | Q99705 | 9/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.51 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CCR4 | P51679 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28258397 | 0.88 | ABL1 (0.60) | ACHESIGMAR1ABL1RIN1 | |
| SCHEMBL28256889 | 0.84 | ALDH1A1 (0.53) | ACHEMCHR1SIGMAR1ABL1RIN1 | |
| SCHEMBL28256920 | 0.84 | ARG1 (0.56) | MCHR1SIGMAR1ABL1RIN1KMT2A | |
| SCHEMBL28256826 | 0.84 | ARG1 (0.53) | SIGMAR1ABL1RIN1KMT2AMEN1 | |
| SCHEMBL28258434 | 0.81 | ACHE (0.52) | ACHESIGMAR1ABL1RIN1KMT2A | |
| SCHEMBL28256965 | 0.81 | CCR3 (0.47) | ABL1RIN1MEN1 | |
| Hydrochloric Acid SCHEMBL28258438 | 0.81 | CHRM3 (0.47) | KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL28256892 | 0.81 | ABL1 (0.54) | ACHESIGMAR1ABL1RIN1 | |
| Hydrochloric Acid SCHEMBL28256857 | 0.80 | TSHR (0.50) | ACHEABL1RIN1KMT2AMEN1 | |
| SCHEMBL28258405 | 0.78 | ALDH1A1 (0.53) | SIGMAR1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104876955-B | Arginase inhibitor and its treatment use | 马尔斯公司 | 2018-11-23 | — | — | CN | disclosed |